Interleukin-12 production pathway

The "Interleukin‑12 production pathway" is not a single molecule or receptor, but rather refers to the complex cellular and molecular processes that regulate the synthesis and secretion of interleukin‑12 (IL‑12), a heterodimeric cytokine composed of p35 and p40 subunits. IL‑12 is primarily produced by activated antigen-presenting cells such as dendritic cells, macrophages, neutrophils, and B lymphoblastoid cells in response to antigenic stimulation[1][2]. The pathway involves upstream signals including interferon gamma (IFN‑γ), which primes macrophages for enhanced IL‑12 production, while tumor necrosis factor alpha (TNFα) can inhibit this process[3]. IL‑12 plays a central role in promoting Th1 immune responses via activation of STAT4 through the JAK–STAT signaling cascade after binding its heterodimeric receptor on T cells and NK cells[2]. Dysregulation of this pathway has been implicated in autoimmunity—where excessive IL‑12 exacerbates disease—and potentially in allergy prevention. Because "production pathways" are not discrete drug targets but rather biological processes involving multiple molecules, this entry does not correspond to a canonical therapeutic target such as an enzyme or receptor.